Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-116660
Filing Date
2025-11-28
Accepted
2025-11-28 08:15:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15181
2 EXHIBIT 99.1 tm2532331d1_ex99-1.htm EX-99.1 19288
  Complete submission text file 0001104659-25-116660.txt   36256
Mailing Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225
Business Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

EIN.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92480 | Film No.: 251532420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)